TIGENIX NV Instrumento Inactivo
Empresa TiGenix NV
Acciones
TIG
BE0003864817
Biotecnología e investigación médica
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 66 | - | |
Koen Huygens
PRN | Corporate Officer/Principal | - | 01/07/01 |
Julian Panes
PRN | Corporate Officer/Principal | - | - |
Mary Carmen Diez
PRN | Corporate Officer/Principal | - | 01/09/14 |
Maria Pascual
LAW | General Counsel | - | - |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Sebastian Wehle
BRD | Director/Board Member | - | 15/06/18 |
Jean Stephenne
CHM | Chairman | 75 | - |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 296 067 856 | 27 758 827 ( 9,376 %) | 0 | 9,376 % |
Información de la empresa
TiGenix NV
Haasrode Researchpark 1724 Romeinse Straat 12
3001, Leuven
+32 1 639 79 37
http://www.tigenix.com
Sector
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| -2,31 % | 103 mil M | |
| +0,56 % | 95,28 mil M | |
| +1,69 % | 22,15 mil M | |
| -17,37 % | 21,02 mil M | |
| -9,30 % | 18,15 mil M | |
| -41,01 % | 16,74 mil M | |
| -14,85 % | 16,05 mil M | |
| +3,21 % | 13,68 mil M | |
| +33,54 % | 12,17 mil M |
